The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fraxiparine Market Research Report 2025
Synopsis
Nadroparin belongs to the class of medications known as anticoagulants or antithrombotic agents. These medications reduce the clotting ability of the blood and can reduce the risk of harmful blood clots forming in blood vessels. Nadroparin is used to prevent and treat deep vein thrombosis (DVT). This condition leads to the formation of blood clots in the blood vessels in the leg. These blood clots can sometimes travel to the lungs and block blood vessels there, resulting in a serious condition known as pulmonary embolism.
The global Fraxiparine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fraxiparine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fraxiparine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fraxiparine include Eisai Inc, Mitsubishi Tanabe Pharma Corporation, Aspen Holdings, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Sanofi S.A, GlaxoSmithKline Plc and Bayer Healthcare AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fraxiparine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fraxiparine.
Report Scope
The Fraxiparine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fraxiparine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fraxiparine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai Inc
Mitsubishi Tanabe Pharma Corporation
Aspen Holdings
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb Company
Sanofi S.A
GlaxoSmithKline Plc
Bayer Healthcare AG
Boehringer Ingelheim
Abbott
Segment by Type
Anticoagulant
Antithrombotic
Segment by Application
General Surgery
Orthopaedic Surgery
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fraxiparine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fraxiparine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nadroparin belongs to the class of medications known as anticoagulants or antithrombotic agents. These medications reduce the clotting ability of the blood and can reduce the risk of harmful blood clots forming in blood vessels. Nadroparin is used to prevent and treat deep vein thrombosis (DVT). This condition leads to the formation of blood clots in the blood vessels in the leg. These blood clots can sometimes travel to the lungs and block blood vessels there, resulting in a serious condition known as pulmonary embolism.
The global Fraxiparine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fraxiparine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fraxiparine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fraxiparine include Eisai Inc, Mitsubishi Tanabe Pharma Corporation, Aspen Holdings, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Sanofi S.A, GlaxoSmithKline Plc and Bayer Healthcare AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fraxiparine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fraxiparine.
Report Scope
The Fraxiparine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fraxiparine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fraxiparine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai Inc
Mitsubishi Tanabe Pharma Corporation
Aspen Holdings
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb Company
Sanofi S.A
GlaxoSmithKline Plc
Bayer Healthcare AG
Boehringer Ingelheim
Abbott
Segment by Type
Anticoagulant
Antithrombotic
Segment by Application
General Surgery
Orthopaedic Surgery
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fraxiparine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fraxiparine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fraxiparine Market Overview
1.1 Product Overview and Scope of Fraxiparine
1.2 Fraxiparine Segment by Type
1.2.1 Global Fraxiparine Market Value Comparison by Type (2024-2030)
1.2.2 Anticoagulant
1.2.3 Antithrombotic
1.3 Fraxiparine Segment by Application
1.3.1 Global Fraxiparine Market Value by Application: (2024-2030)
1.3.2 General Surgery
1.3.3 Orthopaedic Surgery
1.3.4 Others
1.4 Global Fraxiparine Market Size Estimates and Forecasts
1.4.1 Global Fraxiparine Revenue 2019-2030
1.4.2 Global Fraxiparine Sales 2019-2030
1.4.3 Global Fraxiparine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fraxiparine Market Competition by Manufacturers
2.1 Global Fraxiparine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fraxiparine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fraxiparine Average Price by Manufacturers (2019-2024)
2.4 Global Fraxiparine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fraxiparine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fraxiparine, Product Type & Application
2.7 Fraxiparine Market Competitive Situation and Trends
2.7.1 Fraxiparine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fraxiparine Players Market Share by Revenue
2.7.3 Global Fraxiparine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fraxiparine Retrospective Market Scenario by Region
3.1 Global Fraxiparine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fraxiparine Global Fraxiparine Sales by Region: 2019-2030
3.2.1 Global Fraxiparine Sales by Region: 2019-2024
3.2.2 Global Fraxiparine Sales by Region: 2025-2030
3.3 Global Fraxiparine Global Fraxiparine Revenue by Region: 2019-2030
3.3.1 Global Fraxiparine Revenue by Region: 2019-2024
3.3.2 Global Fraxiparine Revenue by Region: 2025-2030
3.4 North America Fraxiparine Market Facts & Figures by Country
3.4.1 North America Fraxiparine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fraxiparine Sales by Country (2019-2030)
3.4.3 North America Fraxiparine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fraxiparine Market Facts & Figures by Country
3.5.1 Europe Fraxiparine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fraxiparine Sales by Country (2019-2030)
3.5.3 Europe Fraxiparine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fraxiparine Market Facts & Figures by Country
3.6.1 Asia Pacific Fraxiparine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fraxiparine Sales by Country (2019-2030)
3.6.3 Asia Pacific Fraxiparine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fraxiparine Market Facts & Figures by Country
3.7.1 Latin America Fraxiparine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fraxiparine Sales by Country (2019-2030)
3.7.3 Latin America Fraxiparine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fraxiparine Market Facts & Figures by Country
3.8.1 Middle East and Africa Fraxiparine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fraxiparine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fraxiparine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fraxiparine Sales by Type (2019-2030)
4.1.1 Global Fraxiparine Sales by Type (2019-2024)
4.1.2 Global Fraxiparine Sales by Type (2025-2030)
4.1.3 Global Fraxiparine Sales Market Share by Type (2019-2030)
4.2 Global Fraxiparine Revenue by Type (2019-2030)
4.2.1 Global Fraxiparine Revenue by Type (2019-2024)
4.2.2 Global Fraxiparine Revenue by Type (2025-2030)
4.2.3 Global Fraxiparine Revenue Market Share by Type (2019-2030)
4.3 Global Fraxiparine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fraxiparine Sales by Application (2019-2030)
5.1.1 Global Fraxiparine Sales by Application (2019-2024)
5.1.2 Global Fraxiparine Sales by Application (2025-2030)
5.1.3 Global Fraxiparine Sales Market Share by Application (2019-2030)
5.2 Global Fraxiparine Revenue by Application (2019-2030)
5.2.1 Global Fraxiparine Revenue by Application (2019-2024)
5.2.2 Global Fraxiparine Revenue by Application (2025-2030)
5.2.3 Global Fraxiparine Revenue Market Share by Application (2019-2030)
5.3 Global Fraxiparine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai Inc
6.1.1 Eisai Inc Corporation Information
6.1.2 Eisai Inc Description and Business Overview
6.1.3 Eisai Inc Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai Inc Fraxiparine Product Portfolio
6.1.5 Eisai Inc Recent Developments/Updates
6.2 Mitsubishi Tanabe Pharma Corporation
6.2.1 Mitsubishi Tanabe Pharma Corporation Corporation Information
6.2.2 Mitsubishi Tanabe Pharma Corporation Description and Business Overview
6.2.3 Mitsubishi Tanabe Pharma Corporation Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mitsubishi Tanabe Pharma Corporation Fraxiparine Product Portfolio
6.2.5 Mitsubishi Tanabe Pharma Corporation Recent Developments/Updates
6.3 Aspen Holdings
6.3.1 Aspen Holdings Corporation Information
6.3.2 Aspen Holdings Description and Business Overview
6.3.3 Aspen Holdings Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aspen Holdings Fraxiparine Product Portfolio
6.3.5 Aspen Holdings Recent Developments/Updates
6.4 Pfizer, Inc
6.4.1 Pfizer, Inc Corporation Information
6.4.2 Pfizer, Inc Description and Business Overview
6.4.3 Pfizer, Inc Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer, Inc Fraxiparine Product Portfolio
6.4.5 Pfizer, Inc Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd
6.5.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.5.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Industries Ltd Fraxiparine Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Corporation Information
6.6.2 Bristol-Myers Squibb Company Description and Business Overview
6.6.3 Bristol-Myers Squibb Company Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Company Fraxiparine Product Portfolio
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.7 Sanofi S.A
6.6.1 Sanofi S.A Corporation Information
6.6.2 Sanofi S.A Description and Business Overview
6.6.3 Sanofi S.A Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi S.A Fraxiparine Product Portfolio
6.7.5 Sanofi S.A Recent Developments/Updates
6.8 GlaxoSmithKline Plc
6.8.1 GlaxoSmithKline Plc Corporation Information
6.8.2 GlaxoSmithKline Plc Description and Business Overview
6.8.3 GlaxoSmithKline Plc Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlaxoSmithKline Plc Fraxiparine Product Portfolio
6.8.5 GlaxoSmithKline Plc Recent Developments/Updates
6.9 Bayer Healthcare AG
6.9.1 Bayer Healthcare AG Corporation Information
6.9.2 Bayer Healthcare AG Description and Business Overview
6.9.3 Bayer Healthcare AG Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bayer Healthcare AG Fraxiparine Product Portfolio
6.9.5 Bayer Healthcare AG Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Fraxiparine Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 Abbott
6.11.1 Abbott Corporation Information
6.11.2 Abbott Fraxiparine Description and Business Overview
6.11.3 Abbott Fraxiparine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Abbott Fraxiparine Product Portfolio
6.11.5 Abbott Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fraxiparine Industry Chain Analysis
7.2 Fraxiparine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fraxiparine Production Mode & Process
7.4 Fraxiparine Sales and Marketing
7.4.1 Fraxiparine Sales Channels
7.4.2 Fraxiparine Distributors
7.5 Fraxiparine Customers
8 Fraxiparine Market Dynamics
8.1 Fraxiparine Industry Trends
8.2 Fraxiparine Market Drivers
8.3 Fraxiparine Market Challenges
8.4 Fraxiparine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Fraxiparine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Fraxiparine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Fraxiparine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Fraxiparine Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Fraxiparine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Fraxiparine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Fraxiparine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Fraxiparine Average Price (US$/g) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Fraxiparine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Fraxiparine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fraxiparine, Product Type & Application
Table 12. Global Key Manufacturers of Fraxiparine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fraxiparine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fraxiparine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fraxiparine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Fraxiparine Sales by Region (2019-2024) & (MT)
Table 18. Global Fraxiparine Sales Market Share by Region (2019-2024)
Table 19. Global Fraxiparine Sales by Region (2025-2030) & (MT)
Table 20. Global Fraxiparine Sales Market Share by Region (2025-2030)
Table 21. Global Fraxiparine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Fraxiparine Revenue Market Share by Region (2019-2024)
Table 23. Global Fraxiparine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Fraxiparine Revenue Market Share by Region (2025-2030)
Table 25. North America Fraxiparine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Fraxiparine Sales by Country (2019-2024) & (MT)
Table 27. North America Fraxiparine Sales by Country (2025-2030) & (MT)
Table 28. North America Fraxiparine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Fraxiparine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Fraxiparine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Fraxiparine Sales by Country (2019-2024) & (MT)
Table 32. Europe Fraxiparine Sales by Country (2025-2030) & (MT)
Table 33. Europe Fraxiparine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Fraxiparine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Fraxiparine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Fraxiparine Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Fraxiparine Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Fraxiparine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Fraxiparine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fraxiparine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Fraxiparine Sales by Country (2019-2024) & (MT)
Table 42. Latin America Fraxiparine Sales by Country (2025-2030) & (MT)
Table 43. Latin America Fraxiparine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Fraxiparine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Fraxiparine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Fraxiparine Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Fraxiparine Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Fraxiparine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Fraxiparine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Fraxiparine Sales (MT) by Type (2019-2024)
Table 51. Global Fraxiparine Sales (MT) by Type (2025-2030)
Table 52. Global Fraxiparine Sales Market Share by Type (2019-2024)
Table 53. Global Fraxiparine Sales Market Share by Type (2025-2030)
Table 54. Global Fraxiparine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Fraxiparine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Fraxiparine Revenue Market Share by Type (2019-2024)
Table 57. Global Fraxiparine Revenue Market Share by Type (2025-2030)
Table 58. Global Fraxiparine Price (US$/g) by Type (2019-2024)
Table 59. Global Fraxiparine Price (US$/g) by Type (2025-2030)
Table 60. Global Fraxiparine Sales (MT) by Application (2019-2024)
Table 61. Global Fraxiparine Sales (MT) by Application (2025-2030)
Table 62. Global Fraxiparine Sales Market Share by Application (2019-2024)
Table 63. Global Fraxiparine Sales Market Share by Application (2025-2030)
Table 64. Global Fraxiparine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Fraxiparine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Fraxiparine Revenue Market Share by Application (2019-2024)
Table 67. Global Fraxiparine Revenue Market Share by Application (2025-2030)
Table 68. Global Fraxiparine Price (US$/g) by Application (2019-2024)
Table 69. Global Fraxiparine Price (US$/g) by Application (2025-2030)
Table 70. Eisai Inc Corporation Information
Table 71. Eisai Inc Description and Business Overview
Table 72. Eisai Inc Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 73. Eisai Inc Fraxiparine Product
Table 74. Eisai Inc Recent Developments/Updates
Table 75. Mitsubishi Tanabe Pharma Corporation Corporation Information
Table 76. Mitsubishi Tanabe Pharma Corporation Description and Business Overview
Table 77. Mitsubishi Tanabe Pharma Corporation Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 78. Mitsubishi Tanabe Pharma Corporation Fraxiparine Product
Table 79. Mitsubishi Tanabe Pharma Corporation Recent Developments/Updates
Table 80. Aspen Holdings Corporation Information
Table 81. Aspen Holdings Description and Business Overview
Table 82. Aspen Holdings Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 83. Aspen Holdings Fraxiparine Product
Table 84. Aspen Holdings Recent Developments/Updates
Table 85. Pfizer, Inc Corporation Information
Table 86. Pfizer, Inc Description and Business Overview
Table 87. Pfizer, Inc Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 88. Pfizer, Inc Fraxiparine Product
Table 89. Pfizer, Inc Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Ltd Corporation Information
Table 91. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 92. Teva Pharmaceutical Industries Ltd Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Industries Ltd Fraxiparine Product
Table 94. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 95. Bristol-Myers Squibb Company Corporation Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 98. Bristol-Myers Squibb Company Fraxiparine Product
Table 99. Bristol-Myers Squibb Company Recent Developments/Updates
Table 100. Sanofi S.A Corporation Information
Table 101. Sanofi S.A Description and Business Overview
Table 102. Sanofi S.A Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 103. Sanofi S.A Fraxiparine Product
Table 104. Sanofi S.A Recent Developments/Updates
Table 105. GlaxoSmithKline Plc Corporation Information
Table 106. GlaxoSmithKline Plc Description and Business Overview
Table 107. GlaxoSmithKline Plc Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 108. GlaxoSmithKline Plc Fraxiparine Product
Table 109. GlaxoSmithKline Plc Recent Developments/Updates
Table 110. Bayer Healthcare AG Corporation Information
Table 111. Bayer Healthcare AG Description and Business Overview
Table 112. Bayer Healthcare AG Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 113. Bayer Healthcare AG Fraxiparine Product
Table 114. Bayer Healthcare AG Recent Developments/Updates
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 118. Boehringer Ingelheim Fraxiparine Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Abbott Corporation Information
Table 121. Abbott Description and Business Overview
Table 122. Abbott Fraxiparine Sales (MT), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 123. Abbott Fraxiparine Product
Table 124. Abbott Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Fraxiparine Distributors List
Table 128. Fraxiparine Customers List
Table 129. Fraxiparine Market Trends
Table 130. Fraxiparine Market Drivers
Table 131. Fraxiparine Market Challenges
Table 132. Fraxiparine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fraxiparine
Figure 2. Global Fraxiparine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Fraxiparine Market Share by Type in 2023 & 2030
Figure 4. Anticoagulant Product Picture
Figure 5. Antithrombotic Product Picture
Figure 6. Global Fraxiparine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Fraxiparine Market Share by Application in 2023 & 2030
Figure 8. General Surgery
Figure 9. Orthopaedic Surgery
Figure 10. Others
Figure 11. Global Fraxiparine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Fraxiparine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Fraxiparine Sales (2019-2030) & (MT)
Figure 14. Global Fraxiparine Average Price (US$/g) & (2019-2030)
Figure 15. Fraxiparine Report Years Considered
Figure 16. Fraxiparine Sales Share by Manufacturers in 2023
Figure 17. Global Fraxiparine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Fraxiparine Players: Market Share by Revenue in 2023
Figure 19. Fraxiparine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Fraxiparine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Fraxiparine Sales Market Share by Country (2019-2030)
Figure 22. North America Fraxiparine Revenue Market Share by Country (2019-2030)
Figure 23. United States Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Fraxiparine Sales Market Share by Country (2019-2030)
Figure 26. Europe Fraxiparine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Fraxiparine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Fraxiparine Revenue Market Share by Region (2019-2030)
Figure 34. China Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Fraxiparine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Fraxiparine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Fraxiparine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Fraxiparine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Fraxiparine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Fraxiparine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Fraxiparine by Type (2019-2030)
Figure 55. Global Fraxiparine Price (US$/g) by Type (2019-2030)
Figure 56. Global Sales Market Share of Fraxiparine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Fraxiparine by Application (2019-2030)
Figure 58. Global Fraxiparine Price (US$/g) by Application (2019-2030)
Figure 59. Fraxiparine Value Chain
Figure 60. Fraxiparine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
